Logo image of MDGS

MEDIGUS LTD - SPON ADR (MDGS) Stock Earnings & Estimates

NASDAQ:MDGS - US58471G4091 - ADR

2.36 USD
+0.18 (+8.28%)
Last: 4/17/2024, 8:12:04 PM
2.6 USD
+0.24 (+10.17%)
After Hours: 4/17/2024, 8:12:04 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023
Revenue
YoY % growth
MDGS revenue by date.MDGS revenue by date.
530K
96.30%
10.12M
1,809.43%
91.86M
807.71%
101.3M
10.28%
EBITDA
YoY % growth
MDGS ebitda by date.MDGS ebitda by date.
-7.29M
48.73%
-7.87M
-7.96%
-5.34M
32.15%
N/A
EBIT
YoY % growth
MDGS ebit by date.MDGS ebit by date.
-7.46M
47.83%
-8.19M
-9.79%
-8.58M
-4.76%
-9.3M
-8.40%
Operating Margin
MDGS operating margin by date.MDGS operating margin by date.
-1,407.55%-80.93%-9.34%-9.18%
EPS
YoY % growth
MDGS eps by date.MDGS eps by date.
N/AN/A
25.00%
N/A
-21,400.00%
-4.90
25.58%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
MDGS Yearly EPS VS EstimatesMDGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2020 2021 2022 2023 -5 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth
53.39M
52.72%
%
Q4 2022
Q2Q % growth
56.9M
636.09%
%
Q2 2022
Q2Q % growth
34.96M
1,362.76%
%
Q4 2021
Q2Q % growth
7.73M
1,580.43%
%
Q2 2021
Q2Q % growth
2.39M
3,314.29%
%
Q4 2020
Q2Q % growth
460K
253.85%
%
Q2 2020
Q2Q % growth
70K
-50.00%
%
MDGS Yearly Revenue VS EstimatesMDGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%